Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes

被引:41
|
作者
Ohno-Nakahara, M
Honda, K
Tanimoto, K
Tanaka, N
Doi, T
Suzuki, A
Yoneno, K
Nakatani, Y
Ueki, M
Ohno, S
Knudson, W
Knudson, CB
Tanne, K
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Minami Ku, Hiroshima 7348553, Japan
[2] Rush Univ, Med Ctr, Rush Med Coll, Dept Biochem, Chicago, IL 60612 USA
来源
JOURNAL OF BIOCHEMISTRY | 2004年 / 135卷 / 05期
关键词
CD44; chondrocytes; hyaluronan; hyaluronidase; matrix metalloproteinase (MMP);
D O I
10.1093/jb/mvh069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, the effects of fragmentation of the glycosoaminoglycans of the cell-associated matrix by hyaluronidase (HAase) on the expression of CD44 receptor and matrix metalloproteinase (MMP) mRNAs in cultured articular chondrocytes were examined. Chondrocytes, isolated from rabbit and bovine articular cartilage, were treated with bovine testicular HAase (0-200 units/ml) in the presence or absence of an antibody for CD44. The mRNA levels of CD44, CD44 variant (CD44v), MMPs (MMP-1, 3 and -9), and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) were determined by RT-PCR. The treatment of cultured chondrocytes with HAase resulted in the production of low molecular weight fragments of hyaluronan (HA). The expression of CD44, CD44v and MMP (MMP-1, -3 and -9) mRNAs, but not TIMP-1 or TIMP-2 mRNA, was up-regulated in the cultures treated with HAase, whereas this expression was not affected by treatment with purified HA of 1.0 x 10(5) Da. Furthermore, the induction of CD44 and MMPs on treatment with HAase was suppressed by an anti-CD44 antibody. The results suggest that the fragmentation of HA may lead to cartilage destruction in terms of the enhanced expression of MMPs as well as the upregulation of CD44.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 50 条
  • [21] EXPRESSION OF CD44 MOLECULES AND CD44 LIGANDS DURING HUMAN THYMIC FETAL DEVELOPMENT - EXPRESSION OF CD44 ISOFORMS IS DEVELOPMENTALLY-REGULATED
    PATEL, DD
    HALE, LP
    WHICHARD, LP
    RADCLIFF, G
    MACKAY, CR
    HAYNES, BF
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) : 277 - 286
  • [22] Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region
    Verkaik, NS
    van Steenbrugge, GJ
    van Weerden, WM
    Bussemakers, MJ
    van der Kwast, TH
    LABORATORY INVESTIGATION, 2000, 80 (08) : 1291 - 1298
  • [23] Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease
    Salter, DM
    Godolphin, JL
    Gourlay, MS
    Lawson, MF
    Hughes, DE
    Dunne, E
    JOURNAL OF PATHOLOGY, 1996, 179 (04): : 396 - 402
  • [24] Lack of a consistent relationship between demethylation of the CD44 promoter and CD44 expression
    Hyman, R
    IMMUNOGENETICS, 2002, 53 (10-11) : 914 - 924
  • [25] Lack of a consistent relationship between demethylation of the CD44 promoter and CD44 expression
    Robert Hyman
    Immunogenetics, 2002, 53 : 914 - 924
  • [26] EXPRESSION OF CD44 AND CD44 VARIANTS IN NORMAL PROSTATE TISSUE AND PROSTATIC ADENOCARCINOMA
    GRIGNON, D
    CHEN, Y
    SLEEMAN, J
    SAKR, W
    SARKAR, F
    CRISSMAN, J
    LABORATORY INVESTIGATION, 1995, 72 (01) : A77 - A77
  • [27] Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis
    Grisar, J.
    Munk, M.
    Steiner, C. W.
    Amoyo-Minar, L.
    Tohidast-Akrad, M.
    Zenz, P.
    Steiner, G.
    Smolen, J. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) : 64 - 72
  • [28] CD44 expression in astrocytic tumors
    Ylagan, L
    Quinn, B
    LABORATORY INVESTIGATION, 1997, 76 (01) : 890 - 890
  • [29] CD44 EXPRESSION ON MURINE TISSUES
    KENNEL, SJ
    LANKFORD, TK
    FOOTE, LJ
    SHINPOCK, SG
    STRINGER, C
    JOURNAL OF CELL SCIENCE, 1993, 104 : 373 - 382
  • [30] Expression of CD44 variants in osteosarcoma
    Kuryu, M
    Ozaki, T
    Nishida, K
    Shibahara, M
    Kawai, A
    Inoue, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) : 646 - 652